Concentriq Enterprise Pathology Platform

Concentriq® is an enterprise pathology platform developed by Proscia, purpose-built to accelerate drug discovery, development, and diagnostics in the era of precision medicine. By unifying data, teams, and applications, Concentriq empowers pathologists and scientists to harness the full potential of digital pathology and AI with unparalleled efficiency and impact. The platform serves as a unifying foundation for both clinical operations and therapeutic R&D, and is trusted daily by more than 12,000 pathologists and scientists across diagnostic laboratories, academic medical centers, commercial labs, CROs, and 16 of the top 20 pharma leaders worldwide.

Concentriq is structured around three purpose-built products that address distinct needs across the pathology spectrum — from life sciences research to clinical diagnostics — all powered by a shared AI-driven infrastructure and open platform architecture.

Purpose-Built Products

• Concentriq LS serves as the central hub for image-based scientific workflows spanning biomarker discovery through early-stage clinical trials. It transforms siloed, underutilized data into an AI-optimized digital foundation, enabling teams to leverage proprietary and real-world data alongside powerful AI capabilities — including Concentriq Embeddings — to accelerate the development of life-saving therapies.
• Concentriq AP enables laboratories to achieve 100% digitization and adopt industry-leading AI applications for precise insights and fast, efficient operations. Designed to be intuitive and innovative, it is built for pathologists, laboratory directors, and IT teams alike, and has earned the top KLAS score for digital pathology.
• Concentriq AP-Dx holds FDA 510(k) clearance for primary diagnosis and offers pathologists an intuitive experience for viewing, interpreting, and managing whole slide images. It is designed for clinical settings of all sizes — from individual reference laboratories to large hospital systems — and supports late-stage clinical trials as well as everyday diagnostic workflows.

AI and Open Platform Capabilities

• Concentriq offers the market's most extensive portfolio of AI applications for both research and diagnostics, seamlessly integrating best-in-class AI-powered analysis into pathology workflows to enhance efficiency and outcomes.
• The platform provides REST APIs, event-driven architecture, a data warehouse, and a foundation model integrator, giving data scientists and developers the tools to build next-generation AI models with flexibility and speed.
• The Proscia Ready Partner Alliance surrounds customer labs with a community of trusted partners focused on delivering world-class interoperability, covering scanners, AI applications, and more, to ensure successful implementation of a comprehensive digital strategy.

Cloud Deployment

• Scalable and flexible cloud deployment options are available for research and diagnostic teams of any size.
• Proscia-hosted cloud can be deployed quickly — up and running in just days upon completion of contracting and professional services.
• Cloud hosting represents a fraction of the cost and effort compared to customer-hosted on-premise or customer-managed cloud solutions.
• The platform is compliant and secure, featuring 24/7 monitoring with near real-time alerting and response.
• Infrastructure automatically scales up or down in response to workload demands.

Concentriq has been recognized as the highest-rated digital pathology platform in the 2026 KLAS Digital Pathology report, earning Best in KLAS for Digital Pathology in Europe and the top score in the US, with 100% of surveyed customers stating they would buy again. Proscia was also named to the Fierce 15 by Fierce Medtech for AI pathology leadership in 2025.